Mechanistically, SRSF9 inhibited erastin‐induced ferroptosis and thus drives tumorigenesis by enhancing GPX4 levels.[109] Cytoglobin treatment of CRC cells increased ROS accumulation and disrupted mitochondrial function, thereby increasing ferroptosis in CRC cells. The gene discussed is SRSF9; the disease is colorectal carcinoma.